View Cart  

EMA Allows Sponsors to Reference Non-EU Products in Applications

A A
The European Medicines Agency (EMA) will soon allow biosimilars sponsors to reference biologics made outside the European Economic Area (EEA) in some preclinical and clinical studies required for approval.

To View This Article:

Login

Subscribe To Drug Industry Daily